Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1753376

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1753376

Beyond the Pill

PUBLISHED:
PAGES: 296 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Beyond the Pill Market to Reach US$381.9 Million by 2030

The global market for Beyond the Pill estimated at US$287.2 Million in the year 2024, is expected to reach US$381.9 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Services Offering, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$138.3 Million by the end of the analysis period. Growth in the Monitoring Offering segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$78.2 Million While China is Forecast to Grow at 7.5% CAGR

The Beyond the Pill market in the U.S. is estimated at US$78.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$74.6 Million by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global “Beyond the Pill” Market - Key Trends & Drivers Summarized

Why Is the “Beyond the Pill” Concept Revolutionizing Modern Healthcare Delivery?

The “Beyond the Pill” concept is transforming healthcare from a transactional model focused solely on medication sales to a holistic, outcomes-based approach that addresses the full spectrum of patient needs. Originating from the pharmaceutical industry’s effort to add value to drug therapies, this model includes services and technologies that support adherence, patient education, remote monitoring, diagnostics, and personalized interventions. As chronic disease burdens rise and healthcare systems worldwide grapple with unsustainable costs, “Beyond the Pill” initiatives are becoming vital tools in improving patient outcomes and driving cost-effective care. Rather than viewing the pill as the endpoint, healthcare providers and pharmaceutical companies now treat it as the starting point for broader, integrated care pathways. For example, companies offer digital tools-such as mobile health apps, teleconsultation platforms, and wearable devices-that help track patient vitals and medication compliance in real time. These services enable earlier intervention, reduce hospital readmissions, and foster long-term engagement between patients and care teams. The focus is shifting from selling pills to delivering results, and patients are responding positively to more personalized, interactive care models. Regulatory agencies and payers are also recognizing the potential of “Beyond the Pill” programs in improving real-world outcomes and are incentivizing their adoption. This paradigm shift is laying the foundation for more resilient, proactive, and patient-centric healthcare systems across the globe.

How Are Digital Health Tools and AI Empowering the “Beyond the Pill” Ecosystem?

Technology is at the heart of the “Beyond the Pill” revolution, enabling unprecedented personalization, scalability, and real-time feedback in patient care. Digital health tools such as mobile apps, wearables, smart pill bottles, and remote monitoring devices are now seamlessly integrated with pharmaceutical treatments, creating a connected ecosystem that bridges the gap between diagnosis, treatment, and ongoing care. Artificial intelligence (AI) and machine learning play a pivotal role in analyzing large datasets generated by these tools, providing predictive insights that help identify at-risk patients, monitor adherence trends, and fine-tune treatment plans. For instance, AI-enabled chatbots and virtual health assistants can guide patients through medication schedules, provide behavioral nudges, and even alert clinicians in case of deteriorating symptoms. Cloud-based platforms allow for centralized data sharing between patients, providers, and payers, enhancing transparency and continuity of care. Pharmaceutical companies are increasingly entering partnerships with health tech firms to co-develop tailored solutions that extend therapeutic value and improve patient loyalty. These collaborations enable the delivery of companion diagnostics, virtual coaching, symptom trackers, and even AI-driven mental health support-all aligned with the original prescription. Additionally, blockchain technology is beginning to play a role in ensuring data security and traceability within the ecosystem, which is vital for compliance and trust. Together, these technological advancements are reshaping the value chain of the pharmaceutical industry and placing data-driven care coordination at the center of therapeutic interventions.

What Stakeholders and Healthcare Trends Are Accelerating Adoption of “Beyond the Pill” Models?

The adoption of “Beyond the Pill” strategies is being rapidly accelerated by the evolving expectations of patients, healthcare providers, payers, and policymakers who are all seeking more value from pharmaceutical interventions. Patients, empowered by digital tools and better health literacy, now demand care that is not only effective but also personalized, convenient, and continuous. They expect their healthcare journeys to be supported by services that go beyond medication-such as nutritional advice, mental health support, and lifestyle coaching-making holistic care a necessity rather than a luxury. Healthcare providers, particularly those working under value-based care or accountable care organizations (ACOs), are incentivized to prevent disease progression and avoid costly readmissions, leading to increased interest in companion services and remote monitoring. Payers and insurers, looking to control escalating chronic care costs, are backing integrated models that promote medication adherence and preventive health management. Pharmaceutical companies themselves face mounting pressure from patent cliffs, regulatory scrutiny, and public demand for price transparency. To stay competitive and relevant, they are evolving into service-oriented organizations that deliver measurable outcomes rather than just products. Global health challenges-such as aging populations, rising non-communicable diseases, and post-pandemic recovery-further underscore the importance of ongoing patient engagement and health system resilience. Collectively, these shifts are catalyzing a move from fragmented, reactionary care to coordinated, proactive health management, positioning “Beyond the Pill” as a critical framework for 21st-century healthcare delivery.

What Is Fueling the Growth in the Global “Beyond the Pill” Market?

The growth in the global “Beyond the Pill” market is driven by several converging forces, including technological advancement, evolving healthcare economics, regulatory incentives, and patient-centric business strategies. The growing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer necessitates long-term care models that extend far beyond simple drug administration. This demand is fueling investment in digital therapeutics, connected devices, telemedicine services, and patient support programs that work in tandem with pharmaceutical treatments. As governments and insurance providers shift toward value-based reimbursement models, there is increasing emphasis on real-world outcomes, adherence, and total cost of care-objectives that “Beyond the Pill” programs are uniquely positioned to address. The pharmaceutical industry is responding by embedding services into product launches, building digital platforms, and creating end-to-end patient ecosystems that include education, monitoring, and feedback loops. Additionally, the widespread penetration of smartphones and internet access, even in emerging markets, is enabling scalable, data-rich solutions that were previously inaccessible. Strategic alliances between pharma companies and digital health startups are accelerating innovation and shortening time-to-market for new service offerings. Regulatory bodies in regions such as the EU, U.S., and Asia-Pacific are increasingly supportive of these integrated care approaches, providing frameworks for digital health certification and reimbursement. Furthermore, investor interest in digital health and health-tech services is at an all-time high, infusing the market with capital needed for R&D and expansion. Together, these drivers are creating a vibrant and high-growth “Beyond the Pill” ecosystem that is redefining the pharmaceutical industry’s role-not just as a supplier of drugs, but as a comprehensive partner in long-term health outcomes.

SCOPE OF STUDY:

The report analyzes the Beyond the Pill market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Services Offering, Monitoring Offering, Assistance Offering, Information Offering, Education Offering); Therapeutic Area (Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area, Asthma Therapeutic Area, Other Therapeutic Areas)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • Bayer AG
  • Bio-Images Drug Delivery Ltd
  • CapsoVision Inc.
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • etectRx Inc.
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc (GSK)
  • Johnson & Johnson
  • Mankind Pharma Ltd.
  • Medtronic plc
  • Merck & Co., Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP36365

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Beyond the Pill - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Value-Based Care Models Throw the Spotlight on Beyond-the-Pill Strategies to Improve Outcomes
    • Shift Toward Patient-Centric Healthcare Spurs Growth in Digital Therapeutics and Support Programs
    • Pharma's Need to Differentiate in Crowded Markets Strengthens the Business Case for Non-Drug Services
    • Here's How Real-World Evidence Is Driving Adoption of Digital Health Platforms Accompanying Therapies
    • Integration of Companion Apps, Adherence Tools, and Coaching Expands the Addressable Value Proposition
    • Chronic Disease Management Trends Generate Long-Term Opportunities for Behavioral and Educational Interventions
    • Data-Driven Patient Engagement Platforms Accelerate Evolution of the Traditional Drug Lifecycle
    • Rise of Personalized Medicine Drives Development of Customized Digital and Service-Based Add-Ons
    • Telehealth Normalization Reinforces Role of Remote Monitoring and Patient Support Tools
    • Growing Employer Focus on Outcomes-Based Wellness Programs Creates B2B Opportunities for Beyond-the-Pill Offerings
    • Wearables and Connected Devices Propel Integration of Continuous Monitoring into Drug Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Beyond the Pill Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Beyond the Pill by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Beyond the Pill by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Beyond the Pill by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Services Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Services Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Services Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Monitoring Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Monitoring Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Monitoring Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Assistance Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Assistance Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Assistance Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Information Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Information Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Information Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Education Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Education Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Education Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diabetes Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diabetes Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Diabetes Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Oncology Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Oncology Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Oncology Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Cardiovascular Diseases Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Cardiovascular Diseases Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Cardiovascular Diseases Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Asthma Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Asthma Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Asthma Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Beyond the Pill Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • JAPAN
    • Beyond the Pill Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • CHINA
    • Beyond the Pill Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: China 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • EUROPE
    • Beyond the Pill Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Beyond the Pill by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Beyond the Pill by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Beyond the Pill by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • FRANCE
    • Beyond the Pill Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: France 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: France 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • GERMANY
    • Beyond the Pill Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Beyond the Pill Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Beyond the Pill Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Beyond the Pill by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Beyond the Pill by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Beyond the Pill by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Beyond the Pill Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • INDIA
    • Beyond the Pill Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: India 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: India 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Beyond the Pill Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Beyond the Pill by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Beyond the Pill by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Beyond the Pill by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Beyond the Pill Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Beyond the Pill by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Beyond the Pill by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Beyond the Pill by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030
  • AFRICA
    • Beyond the Pill Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Beyond the Pill by Offering - Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Beyond the Pill by Offering - Percentage Breakdown of Value Sales for Services Offering, Monitoring Offering, Assistance Offering, Information Offering and Education Offering for the Years 2014, 2025 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Beyond the Pill by Therapeutic Area - Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Beyond the Pill by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Diabetes Therapeutic Area, Oncology Therapeutic Area, Cardiovascular Diseases Therapeutic Area and Asthma Therapeutic Area for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!